BMRN
Biomarin Pharmaceutical Inc
Price:  
57.29 
USD
Volume:  
1,740,454.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biomarin Relative Valuation

9.3%
Upside

As of 2025-07-19, the Relative Valuation of Biomarin Pharmaceutical Inc (BMRN) is 62.64 USD. This relative valuation is based on P/E multiples. With the latest stock price at 57.29 USD, the upside of Biomarin Pharmaceutical Inc based on Relative Valuation is 9.3%.

The range of the Relative Valuation is 49.25 - 73.93 USD.

Range Selected
Trailing P/E multiples 19.2x - 24.3x 21.8x
Forward P/E multiples 16.5x - 24.8x 22.0x
Fair Price 49.25 - 73.93 62.64
Upside -14.0% - 29.0% 9.3%
57.29 USD
Stock Price
62.64 USD
Fair Price

Biomarin Relative Valuation - Historical P/E Data

Date P/E
2025-07-18 20.97
2025-07-17 21.37
2025-07-16 21.38
2025-07-15 20.73
2025-07-14 21.32
2025-07-11 21.27
2025-07-10 21.53
2025-07-09 21.84
2025-07-08 21.23
2025-07-07 21.02
2025-07-03 21.05
2025-07-02 20.93
2025-07-01 20.57
2025-06-30 20.12
2025-06-27 20.20
2025-06-26 19.80
2025-06-25 19.82
2025-06-24 20.02
2025-06-23 19.80
2025-06-20 20.13
2025-06-18 20.22
2025-06-17 20.13
2025-06-16 20.59
2025-06-13 20.58
2025-06-12 20.97
2025-06-11 20.92
2025-06-10 21.04
2025-06-09 20.82
2025-06-06 20.74
2025-06-05 20.23
2025-06-04 20.54
2025-06-03 20.79
2025-06-02 20.88
2025-05-30 21.26
2025-05-29 21.43
2025-05-28 21.27
2025-05-27 21.27
2025-05-23 21.07
2025-05-22 21.24
2025-05-21 21.41
2025-05-20 21.94
2025-05-19 21.75
2025-05-16 21.70
2025-05-15 21.33
2025-05-14 21.49
2025-05-13 21.88
2025-05-12 22.47
2025-05-09 21.55
2025-05-08 21.90
2025-05-07 21.72